5769-33-5

Usage

Uses

Used in Pharmaceutical Industry:
2,6-Dimethyl-4-bromobenzaldehyde is used as a key intermediate in the synthesis of pharmaceuticals for its potential medicinal applications, particularly in the development of anti-cancer and anti-inflammatory drugs. Its unique chemical structure allows for the creation of new drug candidates that can target specific biological pathways.
Used in Dye Production:
In the dye industry, 2,6-Dimethyl-4-bromobenzaldehyde is utilized as a starting material for the production of various dyes. Its chemical properties enable the creation of a wide range of colors, making it a versatile component in dye manufacturing.
Used in Perfumery:
2,6-Dimethyl-4-bromobenzaldehyde is used as a fragrance ingredient in the perfumery industry due to its strong, pungent odor. It contributes to the development of unique and complex scents in perfumes, colognes, and other aromatic products.
Used in Flavor Industry:
In the flavor industry, 2,6-Dimethyl-4-bromobenzaldehyde is employed as a flavoring agent to impart specific taste profiles to food and beverages. Its distinct aroma and taste characteristics make it a valuable component in the creation of various flavor formulations.

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 206559-43-5 5-bromo-2-iodo-1,3-dimethyl-benzene 
• 4885-02-3 Dichloromethyl methyl ether 
• 556-96-7 5-bromo-1,3-xylene 
• 5757-66-4 4-bromo-2,6-dimethylbenzonitrile 

Downstream Products

• 404337-47-9 bis(4-bromo-2,6-dimethylphenyl)methanol 
• 1224968-75-5 4-(4-bromo-2,6-dimethylphenyl)-2,6-di(quinolin-8-yl)pyridine 
• 127666-70-0 C₂₁H₂₀⁽³⁾HF₃N₂O 
• 127666-70-0 C₂₁H₂₀⁽³⁾HF₃N₂O 
• 127666-70-0 C₂₁H₂₀⁽³⁾HF₃N₂O 
• 127666-69-7 (2E,4E,6E,8E)-9-[2,6-Dimethyl-4-(3-trifluoromethyl-3H-diazirin-3-yl)-phenyl]-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid ethyl ester 
• 127685-64-7 (2E,4E,6E,8E)-9-[2,6-Dimethyl-4-(3-trifluoromethyl-3H-diazirin-3-yl)-phenyl]-3,7-dimethyl-nona-2,4,6,8-tetraenal 
• 127666-75-5 3-[4-(tert-Butyl-dimethyl-silanyloxymethyl)-3,5-dimethyl-phenyl]-3-trifluoromethyl-3H-diazirine 
• 127666-67-5 3-[4-(tert-Butyl-dimethyl-silanyloxymethyl)-3,5-dimethyl-phenyl]-3-trifluoromethyl-diaziridine 
• 127666-74-4 2,6-Dimethyl-4-(3-trifluoromethyl-3H-diazirin-3-yl)-benzaldehyde 
• 127666-68-6 2,6-dimethyl-4<(trifluoromethyl)diazirinyl>benzyl alcohol 
• 127666-66-4 4-bromo-2,6-dimethylbenzyl dimethyl-tert-butylsilyl ether 
• 19111-80-9 2,6-Dimethyl-4-brom-benzonitril-N-oxid 
• 159152-22-4 2,6-dimethyl-4-<2-(trimethylsilyl)ethynyl>benzaldehyde 

Relevant academic research and scientific papers

Spectroscopic Signatures of Resonance Inhibition Reveal Differences in Donor-Bridge and Bridge-Acceptor Couplings

The torsional dependence of the ground state magnetic exchange coupling (J) and the corresponding electronic coupling matrix element (HDA) for eight transition metal complexes possessing donor-acceptor (D-A) biradical ligands is presented. These biradical ligands are composed of an S = 1/2 metal semiquinone (SQ) donor and an S = 1/2 nitronylnitroxide (NN) acceptor, which are coupled to each other via para-phenylene, methyl-substituted para-phenylenes, or a bicyclo[2.2.2]octane ring. The observed trends in electronic absorption and resonance Raman spectral features are in accord with a reduction in electronic and magnetic coupling between D and A units within the framework of our valence bond configuration interaction model. Moreover, our spectroscopic results highlight different orbital mechanisms that modulate coupling in these complexes, which is not manifest in the ferromagnetic JSQ-B-NN values. The work provides new detailed insight into the effects of torsional rotations which contribute to inhomogeneities in experimentally determined exchange couplings, electron transfer rates, and electron transport conductance measurements.

Efficient three-component synthesis of diversely substituted tetrahydro-1H-cyclopenta[c]quinolines

The synthesis of highly functionalized substituted tetrahydro-1H-cyclopenta[c]quinoline (I) and its reduced derivatives hexahydro-1H-cyclopenta[c]quinolines (II) via Povarov reaction in high diastereoselectivity and high to moderate yields is described he

A direct and mild formylation method for substituted benzenes utilizing dichloromethyl methyl ether-silver trifluoromethanesulfonate

A silver trifluoromethanesulfonate (AgOTf)-promoted direct and mild formylation of benzenes has been developed. The reaction utilizing dichloromethyl methyl ether (Cl2CHOMe) and AgOTf powerfully formylated various substituted benzenes under temperature conditions as low as -78 C without losing the protecting groups on the phenolic hydroxyl group.

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

The present invention belongs to the field of EPl receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EPl receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EPl receptor as well as to pharmaceutical compositions comprising them.

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.

Vectorial electron transfer in donor-photosensitizer-acceptor triads based on novel bis-tridentate ruthenium polypyridyl complexes

The first examples of rodlike donor-photosensitizer-acceptor arrays based on bis-2,6-di(quinolin-8-yl)pyridine RuII complexes 1a and 3a for photoinduced electron transfer have been synthesized and investigated. The complexes are synthesized in a convergent manner and are isolated as linear, single isomers. Time-resolved absorption spectroscopy reveals long-lived, photoinduced charge-separated states (τCSS (1a)=140 ns, τCSS (3a)=200 ns) formed by stepwise electron transfer. The overall yields of charge separation (≥50% for complex 1a and ≥95% for complex 3a) are unprecedented for bis-tridentate RuII polypyridyl complexes. This is attributed to the long-lived excited state of the [Ru(dqp)2]2+ complex combined with fast electron transfer from the donor moiety following the initial charge separation. The rodlike arrangement of donor and acceptor gives controlled, vectorial electron transfer, free from the complications of stereoisomeric diversity. Thus, such arrays provide an excellent system for the study of photoinduced electron transfer and, ultimately, the harvesting of solar energy.

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS

This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.